| Control | Low-dose (0.5 mg/l HA) | Medium-dose (10 mg/l HA) | High-dose (100 mg/l HA) | |||
---|---|---|---|---|---|---|---|
 |  | Exposed | Recovered | Exposed | Recovered | Exposed | Recovered |
Splenic necrosis | - | - | - | + | + | ++ | ++ |
Melanomacrophage centers | - | + | + | ++ | ++ | +++ | +++ |
Perivascular fibrosis | - | + | + | ++ | ++ | +++ | +++ |
Thickened Trabeculae | - | - | - | ++ | ++ | +++ | +++ |
Increased sinusoidal space | - | + | + | + | + | ++ | ++ |
Neutrophilic infiltration | - | + | + | + | + | ++ | ++ |
Clogged blood vessels | - | - | - | + | + | ++ | ++ |
White pulp proliferation | - | - | - | + | + | ++ | ++ |